Rate My Professor Anoushka Krishnan

Dr Anoushka Krishnan serves as an Adjunct Clinical Senior Lecturer in the Curtin Medical School within the Faculty of Health Sciences at Curtin University, Perth, Australia. She concurrently practices as a Nephrologist in the Department of Nephrology at Royal Perth Hospital. Krishnan holds the qualifications of MBBS, MSc in Clinical Epidemiology, and MPhil from the University of Sydney, as well as FRACP, Fellowship of the Royal Australasian College of Physicians. She completed her renal training between Perth, Australia, and Vancouver, Canada, prior to undertaking an MPhil focused on the burden of disease in chronic kidney disease patients.

Her academic interests center on nephrology, including glomerular diseases, chronic kidney disease, kidney transplantation, transplant immunology, health services research, and green nephrology for environmental sustainability in dialysis and renal care. Krishnan is a core member of the GlomCon educational committee and has been involved with the Australia and New Zealand Society of Nephrology Environmental Sustainability Committee since 2021. She has authored or co-authored over 30 peer-reviewed publications, cited more than 390 times. Key publications include 'Chronic kidney disease: doing simple things well for those most at risk' (Medicine Today, 2024, co-authored with Jaquelyne T. Hughes), 'Anaemia of Chronic Kidney Disease: What We Know Now' (2017), 'Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis' (American Journal of Kidney Diseases, 2021), 'Rituximab Resistance in Glomerular Diseases: A GlomCon Mini-Review' (Kidney Medicine, 2024), 'Safety, tolerability and efficacy of the use of tixagevimab/cilgavimab as pre-exposure COVID-19 prophylaxis in kidney and simultaneous pancreas kidney transplant recipients' (Internal Medicine Journal, 2025), 'Environmentally sustainable design guide for haemodialysis facilities: An Australian and New Zealand society of Nephrology initiative' (2024), and 'Endothelin Receptor Antagonists for the Treatment of Hypertension: Recent Data from Clinical Trials and Implementation Approach' (2025). She participated in the GlomCon Virtual Glomerular Diseases Fellowship in 2020 and contributes to teaching junior medical staff while simplifying information for patients.